Efficacy studies of an antibody‐drug conjugate PSMA‐ADC in patient‐derived prostate cancer xenografts

VA DiPippo, WC Olson, HM Nguyen, LG Brown… - The …, 2015 - Wiley Online Library
BACKGROUND It is timely and important to develop new treatment modalities for advanced
prostate cancer, because even the newly FDA approved treatments, despite providing …
被引用次数：47 相关文章
[PDF] academia.edu

[PDF][PDF] Efficacy Studies of an Antibody-Drug Conjugate PSMA-ADC in Patient-Derived Prostate Cancer Xenografts

VA DiPippo, WC Olson, HM Nguyen, LG Brown… - The Prostate, 2015 - academia.edu
BACKGROUND. It is timely and important to develop new treatment modalities for advanced
prostate cancer, because even the newly FDA approved treatments, despite providing …

Efficacy studies of an antibody-drug conjugate PSMA-ADC in patient-derived prostate cancer xenografts.

VA DiPippo, WC Olson, HM Nguyen, LG Brown… - The Prostate, 2014 - europepmc.org
Background It is timely and important to develop new treatment modalities for advanced
prostate cancer, because even the newly FDA approved treatments, despite providing …

Efficacy studies of an antibody-drug conjugate PSMA-ADC in patient-derived prostate cancer xenografts

VA DiPippo, WC Olson, HM Nguyen… - The …, 2015 - pubmed.ncbi.nlm.nih.gov
Background It is timely and important to develop new treatment modalities for advanced
prostate cancer, because even the newly FDA approved treatments, despite providing …

[引用][C] Efficacy studies of an antibody-drug conjugate PSMA-ADC in patient-derived prostate cancer xenografts

VA DiPippo, WC Olson, HM Nguyen, LG Brown… - The Prostate, 2014 - cir.nii.ac.jp
Efficacy studies of an antibody-drug conjugate PSMA-ADC in patient-derived prostate cancer
xenografts | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …